Haemonetics (HAE) Tax Provisions (2009 - 2026)

Haemonetics' Tax Provisions history runs 18 years deep, the most recent figure standing at -$8.3 million for Q1 2026.

• On a quarterly basis, Tax Provisions fell 164.69% year-over-year to -$8.3 million in Q1 2026; TTM through Mar 2026 was $30.7 million, a 30.85% decrease from a year earlier, with the FY2026 full-year figure at $30.7 million, down 30.79% from the prior year.
• Tax Provisions declined to -$8.3 million in Q1 2026 per HAE's latest filing, from $15.2 million in the prior quarter.
• Across five years, Tax Provisions topped out at $15.2 million in Q4 2025 and bottomed at -$8.3 million in Q1 2026.
• The 5-year median for Tax Provisions is $8.8 million (2022), against an average of $8.3 million.
• Across the five-year window, Tax Provisions surged 324.21% in 2025 and tumbled 164.69% in 2026, its largest moves.
• Year by year, Tax Provisions stood at $9.3 million in 2022, then soared by 37.8% to $12.8 million in 2023, then declined by 3.03% to $12.4 million in 2024, then gained by 22.86% to $15.2 million in 2025, then slumped by 154.16% to -$8.3 million in 2026.
• Per Business Quant, the three latest HAE Tax Provisions figures stand at -$8.3 million (Q1 2026), $15.2 million (Q4 2025), and $12.6 million (Q3 2025).